Results 231 to 240 of about 1,568,281 (351)

Meta-QTL analysis for mining of candidate genes and constitutive gene network development for viral disease resistance in maize (Zea mays L.). [PDF]

Heliyon
Gupta M, Choudhary M, Singh A, Sheoran S, Kumar H, Singla D, Bohra A, Rakshit S.   +7 more
europepmc   +1 more source

Platelet-Released Factors: Their Role in Viral Disease and Applications for Extracellular Vesicle (EV) Therapy. [PDF]

Int J Mol Sci, 2022
Ostermeier B, Soriano-Sarabia N, Maggirwar SB.   +2 more
europepmc   +1 more source

Clinical Features of Acute Coxsackie B Viral Myocarditis : PROCEEDINGS OF THE III. CONFERENCE ON PREVENTION FOR RHEUMATIC FEVER AND RHEUMATIC HEART DISEASE

, 1979
Hironori Toshima, Y Ohkita, MASAHISA SHINGU   +2 more
openalex   +2 more sources

Lipid Nanoparticle‐Mediated CRISPR‐Cas13a Delivery for the Control of Bacterial Infection

Advanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
New formulations of lipid nanoparticles (LNPs) that can deliver nucleic acids to Gram‐negative bacteria are proposed to combat bacterial infection. The delivery of nucleic acids by LNPs is aided by LNP‐helpers which weaken the bacterial outer membrane. LNPs encapsulating the Cas13a/gRNA expression vector achieve an antibacterial effect in both in vivo ...
Bookun Kim, Hwi Won Seo, Kyuri Lee, Dongeun Yong, Yoon Kyung Park, Yujin Lee, Solip Lee, Do‐Wan Kim, Dajeong Kim, Choong‐Min Ryu   +9 more
wiley   +1 more source

Community perspectives of Ebola Viral Disease in high-risk transmission border regions of Tanzania: a qualitative inquiry. [PDF]

BMC Public Health
Metta E, Mohamed H, Kusena P, Nyamhanga T, Bahuguna S, Kakoko D, Siril N, Araya A, Mwiru A, Magesa S, Makene L, Rwechungura A, Kirakoya FB, Kazaura M, Frumence G.   +14 more
europepmc   +1 more source

Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic. [PDF]

J Exp Med, 2022
Duncan CJA, Skouboe MK, Howarth S, Hollensen AK, Chen R, Børresen ML, Thompson BJ, Stremenova Spegarova J, Hatton CF, Stæger FF, Andersen MK, Whittaker J, Paludan SR, Jørgensen SE, Thomsen MK, Mikkelsen JG, Heilmann C, Buhas D, Øbro NF, Bay JT, Marquart HV, de la Morena MT, Klejka JA, Hirschfeld M, Borgwardt L, Forss I, Masmas T, Poulsen A, Noya F, Rouleau G, Hansen T, Zhou S, Albrechtsen A, Alizadehfar R, Allenspach EJ, Hambleton S, Mogensen TH.   +36 more
europepmc   +1 more source

Juvenile rheumatoid arthritis-a viral disease. [PDF]

, 1976

openalex   +1 more source

Novel Less Toxic, Lymphoid Tissue‐Targeted Lipid Nanoparticles Containing a Vitamin B5‐Derived Ionizable Lipid for mRNA Vaccine Delivery

Advanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
The top‐performing lipid nanoparticle, incorporating a novel ionizable lipid derived from vitamin B5, demonstrates high mRNA transfection efficiency, low toxicity, favorable stability, targeted delivery to lymphoid tissues, and high immunogenicity, showing promise as a carrier for mRNA vaccines for infectious diseases and cancer.
Soyeon Yoo, Muhammad Faisal, Seo‐Hyeon Bae, Kounghwa Youn, Hyo‐Jung Park, Sung Pil Kwon, Il Kwon Hwang, Jisun Lee, Hyeong Jun Kim, Jae‐Hwan Nam, Gyochang Keum, Eun‐Kyoung Bang   +11 more
wiley   +1 more source

Viral Diseases

, 1979
Pravin N. Bhatt, Robert O. Jacoby, Albert M. Jonas   +2 more
openaire   +2 more sources

Tanzania's first Marburg Viral Disease outbreak response: Describing the roles of FELTP graduates and residents. [PDF]

PLOS Glob Public Health
Hussein AK, Kishimba RS, Simba AA, Urio LJ, Lema NA, Mmbaga VM, Mutayoba BK, Malugu NE, Leonard D, Hokororo J, Kelly ME, Paschal A, Ngenzi D, Hellar JA, Kauki GC, Saguti GE, Yoti Z, Mukurasi KI, Mponela M, Mgomella GS, Gatei W, Kaniki I, Swaminathan M, Kwesi EM, Nagu TJ.   +24 more
europepmc   +1 more source